NewEdge Wealth’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Sell
9,602
-6,226
-39% -$198K ﹤0.01% 1069
2026
Q1
$498K Sell
15,828
-7,509
-32% -$237K 0.01% 816
2025
Q4
$688K Buy
23,337
+1,402
+6% +$39K 0.01% 735
2025
Q3
$604K Buy
21,935
+123
+0.6% +$3K 0.01% 696
2025
Q2
$547K Buy
21,812
+3,183
+17% +$73.8K 0.01% 690
2025
Q1
$427K Buy
18,629
+6,041
+48% +$146K 0.01% 692
2024
Q4
$319K Sell
12,588
-4,667
-27% -$118K 0.01% 742
2024
Q3
$430K Buy
17,255
+166
+1% +$4.92K 0.01% 652
2024
Q2
$507K Sell
17,089
-589
-3% -$16.3K 0.01% 548
2024
Q1
$453K Buy
17,678
+4,408
+33% +$122K 0.01% 582
2023
Q4
$380K Buy
13,270
+2,027
+18% +$59.5K 0.01% 563
2023
Q3
$417K Buy
11,243
+893
+9% +$34.1K 0.01% 480
2023
Q2
$404K Sell
10,350
-1,650
-14% -$64.7K 0.01% 493
2023
Q1
$438K Buy
12,000
+2,013
+20% +$63.5K 0.02% 432
2022
Q4
$308K Buy
+9,987
New +$310K 0.01% 448

Other funds holding RTO

NewEdge Wealth's RTO Position: Q2 2026 in Review

NewEdge Wealth reduced its Rentokil (RTO) stake by 39% in Q2 2026, selling an estimated $198K and leaving 9,602 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

NewEdge Wealth first reported a position in RTO in Q4 2022 and has held it in 15 quarters since. The position peaked at $688K in Q4 2025. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • NewEdge Wealth held 9,602 shares of Rentokil worth $275K as of Q2 2026.
  • NewEdge Wealth sold 6,226 Rentokil shares in Q2 2026, an estimated $198K.
  • Rentokil made up ﹤0.01% of NewEdge Wealth's portfolio in Q2 2026, its #1069 holding.
  • NewEdge Wealth first reported a position in Rentokil in Q4 2022 and has held it in 15 quarters since.
  • NewEdge Wealth's Rentokil position peaked at $688K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.